198 related articles for article (PubMed ID: 27121063)
1. USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.
Vogel RI; Pulver T; Heilmann W; Mooneyham A; Mullany S; Zhao X; Shahi M; Richter J; Klein M; Chen L; Ding R; Konecny G; Kommoss S; Winterhoff B; Ghebre R; Bazzaro M
Oncotarget; 2016 May; 7(21):30962-76. PubMed ID: 27121063
[TBL] [Abstract][Full Text] [Related]
2. The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells.
Wang X; Mazurkiewicz M; Hillert EK; Olofsson MH; Pierrou S; Hillertz P; Gullbo J; Selvaraju K; Paulus A; Akhtar S; Bossler F; Khan AC; Linder S; D'Arcy P
Sci Rep; 2016 Jun; 6():26979. PubMed ID: 27264969
[TBL] [Abstract][Full Text] [Related]
3. Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells.
Paulus A; Akhtar S; Caulfield TR; Samuel K; Yousaf H; Bashir Y; Paulus SM; Tran D; Hudec R; Cogen D; Jiang J; Edenfield B; Novak A; Ansell SM; Witzig T; Martin P; Coleman M; Roy V; Ailawadhi S; Chitta K; Linder S; Chanan-Khan A
Blood Cancer J; 2016 Nov; 6(11):e492. PubMed ID: 27813535
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies.
Didier R; Mallavialle A; Ben Jouira R; Domdom MA; Tichet M; Auberger P; Luciano F; Ohanna M; Tartare-Deckert S; Deckert M
Mol Cancer Ther; 2018 Jul; 17(7):1416-1429. PubMed ID: 29703842
[TBL] [Abstract][Full Text] [Related]
5. Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers.
Li J; Chen H; Curcuru JR; Patel S; Johns TO; Patel D; Qian H; Jiang SW
Curr Drug Targets; 2017; 18(10):1158-1164. PubMed ID: 28382859
[TBL] [Abstract][Full Text] [Related]
6. Update on prognostic markers for endometrial cancer.
Binder PS; Mutch DG
Womens Health (Lond); 2014 May; 10(3):277-88. PubMed ID: 24956294
[TBL] [Abstract][Full Text] [Related]
7. Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
Mofers A; Perego P; Selvaraju K; Gatti L; Gullbo J; Linder S; D'Arcy P
PLoS One; 2019; 14(10):e0223807. PubMed ID: 31639138
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
[TBL] [Abstract][Full Text] [Related]
9. Targeting CDK9: A novel biomarker in the treatment of endometrial cancer.
He S; Fang X; Xia X; Hou T; Zhang T
Oncol Rep; 2020 Nov; 44(5):1929-1938. PubMed ID: 32901849
[TBL] [Abstract][Full Text] [Related]
10. MiR-4782-3p inhibited non-small cell lung cancer growth via USP14.
Wu N; Zhang C; Bai C; Han YP; Li Q
Cell Physiol Biochem; 2014; 33(2):457-67. PubMed ID: 24556800
[TBL] [Abstract][Full Text] [Related]
11. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
[TBL] [Abstract][Full Text] [Related]
12. Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.
Ikeda Y; Oda K; Ishihara H; Wada-Hiraike O; Miyasaka A; Kashiyama T; Inaba K; Fukuda T; Sone K; Matsumoto Y; Arimoto T; Maeda D; Ikemura M; Fukayama M; Kawana K; Yano T; Aoki D; Osuga Y; Fujii T
Br J Cancer; 2015 Nov; 113(10):1477-83. PubMed ID: 26554657
[TBL] [Abstract][Full Text] [Related]
13. Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition.
Mazurkiewicz M; Hillert EK; Wang X; Pellegrini P; Olofsson MH; Selvaraju K; D'Arcy P; Linder S
Oncotarget; 2017 Mar; 8(13):21115-21127. PubMed ID: 28423502
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamyl transferase: risk and prognosis of cancer.
Fentiman IS
Br J Cancer; 2012 Apr; 106(9):1467-8. PubMed ID: 22531718
[No Abstract] [Full Text] [Related]
15. Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs.
Ward JA; Pinto-Fernandez A; Cornelissen L; Bonham S; Díaz-Sáez L; Riant O; Huber KVM; Kessler BM; Feron O; Tate EW
J Med Chem; 2020 Apr; 63(7):3756-3762. PubMed ID: 32109059
[TBL] [Abstract][Full Text] [Related]
16. RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment.
Hellweg R; Mooneyham A; Chang Z; Shetty M; Emmings E; Iizuka Y; Clark C; Starr T; Abrahante JH; Schütz F; Konecny G; Argenta P; Bazzaro M
Horm Cancer; 2018 Oct; 9(5):326-337. PubMed ID: 29951943
[TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
[TBL] [Abstract][Full Text] [Related]
19. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.
Kharma B; Baba T; Mandai M; Matsumura N; Murphy SK; Kang HS; Yamanoi K; Hamanishi J; Yamaguchi K; Yoshioka Y; Konishi I
Int J Cancer; 2013 Nov; 133(9):2234-44. PubMed ID: 23595697
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.
Seebacher V; Polterauer S; Grimm C; Rahhal J; Hofstetter G; Bauer EM; Husslein H; Leipold H; Marth C; Reinthaller A; Concin N
Br J Cancer; 2012 Apr; 106(9):1551-5. PubMed ID: 22315051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]